Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta - PubMed (original) (raw)
. 1999 Nov 1;343 Pt 3(Pt 3):673-80.
Affiliations
- PMID: 10527948
- PMCID: PMC1220601
Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta
K K Nelson et al. Biochem J. 1999.
Abstract
Metalloprotease-disintegrins are a family of transmembrane glycoproteins that have a role in fertilization, sperm migration, myoblast fusion, neural development and ectodomain shedding. In the present study we used the yeast two-hybrid system to search for proteins that interact with the cytoplasmic domain of two metalloprotease-disintegrins, tumour necrosis factor alpha convertase (TACE; ADAM17) and MDC9 (ADAM9; meltrin gamma). We have identified mitotic arrest deficient 2 (MAD2) as a binding partner of the TACE cytoplasmic domain, and a novel MAD2-related protein, MAD2beta, as a binding partner of the MDC9 cytoplasmic domain. MAD2beta has 23% sequence identity with MAD2, which is a component of the spindle assembly (or mitotic) checkpoint mechanism. Northern blot analysis of human tissues indicates that MAD2beta mRNA is expressed ubiquitously. The interaction of the TACE and MDC9 cytoplasmic domains with their binding partners has been confirmed biochemically. The independent identification of MAD2 and MAD2beta as potential interacting partners of distinct metalloprotease-disintegrins raises the possibility of a link between metalloprotease-disintegrins and the cell cycle, or of functions for MAD2 and MAD2beta that are not related to cell cycle control.
Similar articles
- Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity.
Roghani M, Becherer JD, Moss ML, Atherton RE, Erdjument-Bromage H, Arribas J, Blackburn RK, Weskamp G, Tempst P, Blobel CP. Roghani M, et al. J Biol Chem. 1999 Feb 5;274(6):3531-40. doi: 10.1074/jbc.274.6.3531. J Biol Chem. 1999. PMID: 9920899 - Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1.
Howard L, Nelson KK, Maciewicz RA, Blobel CP. Howard L, et al. J Biol Chem. 1999 Oct 29;274(44):31693-9. doi: 10.1074/jbc.274.44.31693. J Biol Chem. 1999. PMID: 10531379 - Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein.
Koike H, Tomioka S, Sorimachi H, Saido TC, Maruyama K, Okuyama A, Fujisawa-Sehara A, Ohno S, Suzuki K, Ishiura S. Koike H, et al. Biochem J. 1999 Oct 15;343 Pt 2(Pt 2):371-5. Biochem J. 1999. PMID: 10510302 Free PMC article. - The HORMA domain: a common structural denominator in mitotic checkpoints, chromosome synapsis and DNA repair.
Aravind L, Koonin EV. Aravind L, et al. Trends Biochem Sci. 1998 Aug;23(8):284-6. doi: 10.1016/s0968-0004(98)01257-2. Trends Biochem Sci. 1998. PMID: 9757827 Review. No abstract available. - Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure.
Fahrenholz F, Gilbert S, Kojro E, Lammich S, Postina R. Fahrenholz F, et al. Ann N Y Acad Sci. 2000;920:215-22. doi: 10.1111/j.1749-6632.2000.tb06925.x. Ann N Y Acad Sci. 2000. PMID: 11193153 Review.
Cited by
- Identification of novel interaction between ADAM17 (a disintegrin and metalloprotease 17) and thioredoxin-1.
Aragão AZ, Nogueira ML, Granato DC, Simabuco FM, Honorato RV, Hoffman Z, Yokoo S, Laurindo FR, Squina FM, Zeri AC, Oliveira PS, Sherman NE, Paes Leme AF. Aragão AZ, et al. J Biol Chem. 2012 Dec 14;287(51):43071-82. doi: 10.1074/jbc.M112.364513. Epub 2012 Oct 26. J Biol Chem. 2012. PMID: 23105116 Free PMC article. - Systemic overexpression of TNFα-converting enzyme does not lead to enhanced shedding activity in vivo.
Yoda M, Kimura T, Tohmonda T, Morioka H, Matsumoto M, Okada Y, Toyama Y, Horiuchi K. Yoda M, et al. PLoS One. 2013;8(1):e54412. doi: 10.1371/journal.pone.0054412. Epub 2013 Jan 14. PLoS One. 2013. PMID: 23342154 Free PMC article. - ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers.
Sinnathamby G, Zerfass J, Hafner J, Block P, Nickens Z, Hobeika A, Secord AA, Lyerly HK, Morse MA, Philip R. Sinnathamby G, et al. Clin Exp Immunol. 2011 Mar;163(3):324-32. doi: 10.1111/j.1365-2249.2010.04298.x. Epub 2010 Dec 22. Clin Exp Immunol. 2011. PMID: 21175594 Free PMC article. - The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
Urriola-Muñoz P, Li X, Maretzky T, McIlwain DR, Mak TW, Reyes JG, Blobel CP, Moreno RD. Urriola-Muñoz P, et al. J Cell Physiol. 2018 Mar;233(3):2247-2256. doi: 10.1002/jcp.26097. Epub 2017 Aug 25. J Cell Physiol. 2018. PMID: 28703301 Free PMC article. - The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses.
Byrne T, Coleman HG, Cooper JA, McCluggage WG, McCann A, Furlong F. Byrne T, et al. Oncotarget. 2017 Jun 8;8(60):102223-102234. doi: 10.18632/oncotarget.18414. eCollection 2017 Nov 24. Oncotarget. 2017. PMID: 29254238 Free PMC article.
References
- J Biol Chem. 1998 Oct 23;273(43):27765-7 - PubMed
- J Cell Biol. 1987 Jan;104(1):141-9 - PubMed
- Science. 1998 Nov 13;282(5392):1281-4 - PubMed
- Curr Opin Cell Biol. 1998 Oct;10(5):654-9 - PubMed
- J Cell Biol. 1990 Jul;111(1):69-78 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous